Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 20, 2019
NJII has signed an Industry Participation Agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab.
read more
Thursday, September 10, 2020
NKMax America has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the safety and tolerability of SNK01.
read more
Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.
read more
Noramco and AFC announced a strategic partnership to produce certain US DEA controlled substances for use in the treatment of addiction, abuse prevention, cannabinoids for clinical indications, and ADHD.
read more
Northwest Biotherapeutics and Advent BioServices, a leading contract development and manufacturing organization (CDMO) based in the UK, jointly announce that a MIA license has been approved and issued by the Medicines and Healthcare Products ...
read more
Tuesday, December 11, 2012
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, announced today that the company has been recognized as Manufacturer of the Year by the Chenango County ...
read more
Thursday, October 24, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, today announced that it has changed its name to Norwich Pharma Services. The new name and brand identity ...
read more
Thursday, January 17, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry today announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development ...
read more
Nosopharm and Evotec announced their partnership aimed at advancing NOSO-502, to the clinical stage, as well as developing a second-generation Odilorhabdin drug candidate.
read more
Wednesday, January 04, 2023
MA–Nova Biomedical is pleased to announce the launch of BioProfile FAST CDVTM, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100uL of sample volume. In ...
read more
Thursday, January 02, 2020
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs has received FDA approval for their generic version of Febuxostat 40mg and 80mg tablets.
read more
Wednesday, February 24, 2021
Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen’s therapies.
read more
Tuesday, November 30, 2021
NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, announced its partnership with Sanofi for the development of new DNA-Encoded Libraries (DELs). This multi-year agreement will see the partners join forces ...
read more
Thursday, December 20, 2018
Novartis has announced an offer to acquire CellforCure from LFB.
read more
Wednesday, April 03, 2019
Novartis has entered into an agreement and plan of merger with AveXis to acquire the US-based clinical stage gene therapy company for $218 per share or a total of $8.7 billion in cash.
read more